Medical Laboratory Observer - Peer Reviewed Management Source for Lab Professionals since 1969. Daily LABline newsletters! Visit us at Facebook, too!
Sarasota, Florida
Joined October 2009
- Tweets8.4K
- Following10.2K
- Followers17.2K
- Likes545
How can chromatograms reveal unexpected hemoglobin patterns? Explore HbA1c methodologies, hemoglobin variant detection, and real-world cases with Dr. Kuanysh Kabytaev.
Nov. 10 | 12 PM EST / 11 AM CST
Free webinar + 1 CE credit.
Register: ce.mlo-online.com/beyond-the…
HbA1c testing has important limitations. Learn how methodology selection, hemoglobinopathies, and alternative measures of glycemia affect patient management.
Join William E. Winter, MD, Nov. 13 for a free CE webinar.
Register: ce.mlo-online.com/what-labor…
🧬 What’s next for next-generation sequencing (NGS)? New sequencing approaches like sequencing by expansion (SBX) aim to improve speed, detect complex genomic features, and support advances in drug discovery, oncology, and precision medicine: mlo-online.com/molecular/art…
Tomorrow! Join Dr. Kenneth Gavina to explore centralized vs. decentralized molecular infectious disease testing, including impacts on workflow and patient care.
📅 Oct. 28 | 1 PM EST / noon CST
🎓 Free webinar + 1 CE credit
Register: ce.mlo-online.com/to-central…
🧪 Could a blood test change Alzheimer’s diagnostics? pTau217 biomarkers could enable earlier detection, with labs playing a key role in reliable testing and workflow integration.
Read more: mlo-online.com/online-exclus…
#ClinicalLaboratory #Diagnostics
Dr. Leslie Saltzman of @Labcorp discusses the Marker Genetic Health Panel, who may benefit from hereditary genetic testing, and how it can provide insight into inherited health risks in this MLO Q&A: bit.ly/4i08qps
#MolecularDiagnostics #GeneticTesting
A leaking pipe above a chemistry analyzer isn’t just a facilities issue—it’s a patient-care risk.
In MLO’s October #LabInnovator Q&A, Jody Dalberg, MLS (ASCP)ꟲᴹ, shares how his team made the case for a new lab and improved workflows.
🔬 Read more: mlo-online.com/management/ca…
A reported HbA1c value may not tell the whole story. Learn how hemoglobin variants, elevated HbF, and chromatogram review can affect HbA1c testing.
Join Dr. Kuanysh Kabytaev Nov. 10 for a free CE webinar.
Register: ce.mlo-online.com/beyond-the…
Decentralizing molecular testing raises important questions about QC, regulatory requirements, test utilization, and patient outcomes.
Join Dr. Kenneth Gavina on Oct. 28 for a free MLO webinar and earn 1 CE credit.
Register: ce.mlo-online.com/to-central…
TOMORROW: This webinar reviews regulatory requirements and consensus standards for full-process quality control in clinical flow cytometry laboratories, highlighting how to monitor the pre-analytic and analytic variables that can affect patient results: ce.mlo-online.com/full-proce…
Centralized or decentralized molecular infectious disease testing—which approach best meets your lab's needs?
Explore the clinical, operational, and financial considerations with Dr. Kenneth Gavina in this free CE webinar on Oct. 28.
Register: ce.mlo-online.com/to-central…
Are routine QC checks enough to monitor the full clinical flow cytometry testing process? Join MLO on Oct. 20 for a free live CE webinar on regulatory requirements and practical approaches to full-process quality control.
Register: bit.ly/4i2zu64
BNP and NT-proBNP are well established in heart failure diagnosis—but could they tell us more? This October CE article explores their prognostic value and what these biomarkers may reveal about future cardiovascular risk: bit.ly/4ATx7Lp #LaboratoryMedicine #HeartFailure
What do ENA concordance numbers really tell laboratories? This analysis takes a closer look at assay validation, study design, platform variability, and what the data mean for labs evaluating ENA testing options: bit.ly/4ycSuoH #AutoimmuneDisease #ClinicalLab #Immunology
Choosing a hemostasis analyzer involves more than comparing speed and price. This Q&A explores what labs should consider when evaluating real-world performance, automation, workflow, support, and long-term value: bit.ly/4yLI5RG
A new diagnostic test may offer little value if it’s simply added to an existing protocol. Explore how a Texas hospital redesigned its sepsis workflow around a rapid host-response test—and what the experience means for other laboratories: bit.ly/3TtatsJ.
Overlapping symptoms can make women’s health diagnoses challenging. Explore how molecular workflows can support comprehensive testing, greater efficiency, and more actionable results for clinical decision-making: bit.ly/46K16b7
#MolecularDiagnostics #ClinicalLaboratory
High throughput is only part of the equation for today’s clinical laboratories. Explore how analyzer scalability, uptime, maintenance, and workflow efficiency can affect laboratory operations as testing demands grow: bit.ly/4Am5YRc
Explore how combining ANA with disease-specific autoantibodies may improve diagnostic accuracy and support earlier evaluation: bit.ly/4iTDmZg.
September is Prostate Cancer Awareness Month. PSA remains a key tool in prostate cancer screening, but an elevated result does not necessarily indicate cancer. Explore how the prostate cancer screening pathway is evolving: bit.ly/4hcNgE3
